How to Help Your Patients Find Coartem in Stock: A Provider's Guide

How to Help Your Patients Find Coartem in Stock: A Provider's Guide

You've diagnosed uncomplicated malaria and Coartem (Artemether/Lumefantrine) is your first-line choice. But there's a good chance your patient is about to call back and tell you their pharmacy doesn't have it. This scenario plays out regularly because Coartem — despite being FDA-approved since 2009 — is simply not stocked by most US retail pharmacies.

This guide gives you a practical, step-by-step approach to help your patients access Coartem (or an appropriate alternative) as quickly as possible.

Current Availability Landscape

Coartem is not in formal shortage per the FDA. The challenge is distribution: with approximately 2,000 malaria cases annually in the US, most pharmacies don't see enough demand to justify stocking this medication. Add in the fact that no generic Artemether/Lumefantrine exists in the US as of 2026, and you have a medication that's manufactured and available in the supply chain but largely absent from retail pharmacy shelves.

The places most likely to have Coartem in stock:

• Hospital outpatient pharmacies (academic medical centers in particular)
• Pharmacies attached to infectious disease or travel medicine clinics
• Specialty infectious disease pharmacies
• Large pharmacies in metropolitan areas with significant international travel populations

The places least likely to have it:

• Retail chain pharmacies (CVS, Walgreens, Rite Aid) in suburban or rural areas
• Small independent pharmacies in areas with low international travel
• Mail-order pharmacies (turnaround time is incompatible with urgent malaria treatment)

Why Patients Can't Find Coartem

When patients report difficulty finding Coartem, the reasons are consistent:

1. The pharmacy doesn't stock it — the most common reason by far. Pharmacies optimize inventory for high-volume medications.
2. The pharmacy can order it, but not fast enough — standard wholesale orders may take 1-2 business days, which is too long for malaria treatment.
3. The patient doesn't know where to look — patients instinctively go to their usual pharmacy, which for most people is a retail chain.
4. Cost surprise — at $140–$280 per course without insurance, some patients hesitate at the register, especially without advance warning about the price.

What Providers Can Do: 5 Steps

Step 1: Check Pharmacy Stock Before Prescribing

The single most impactful thing you can do is confirm Coartem availability before sending the prescription. Use Medfinder for Providers to check real-time inventory at pharmacies near your patient. This takes less than a minute and can save hours of back-and-forth.

If your EMR allows preferred pharmacy selection, route the prescription directly to a pharmacy with confirmed stock.

Step 2: Direct Patients to Hospital Pharmacies

If you practice at or near a hospital, check whether the hospital's outpatient pharmacy carries Coartem. Many academic medical centers and hospitals with ID or travel medicine programs maintain antimalarial stock. If your institution has one, this may be the fastest path to filling the prescription.

Step 3: Prepare a Backup Prescription

Given the availability challenges, consider proactively discussing alternative antimalarials with your patient and having a backup prescription ready. The most practical alternatives:

• Atovaquone/Proguanil (Malarone): Generic available, widely stocked at retail pharmacies, well-tolerated. Often the most seamless substitute.
• Quinine Sulfate + Doxycycline/Clindamycin: Generic, affordable, available at most pharmacies. More complex regimen (two medications, more frequent dosing).
• Chloroquine: Only for malaria from chloroquine-sensitive regions. Very affordable, widely available.

For detailed comparison information to share with patients, see alternatives to Coartem.

Step 4: Discuss Cost Upfront

Patients shouldn't be surprised by the price at the pharmacy counter. Set expectations:

• Coartem cash price: approximately $140–$280 for a full 24-tablet course
• Discount cards (GoodRx, SingleCare) may reduce cost to the $140–$176 range
• Novartis Patient Assistance Foundation can provide Coartem at no cost for eligible uninsured patients (pap.novartis.com, 1-800-277-2254)
• Generic alternatives are substantially cheaper: Atovaquone/Proguanil generics typically run $30–$80

Direct patients to our savings guide: how to save money on Coartem.

Step 5: Document and Educate Your Team

If your practice sees malaria cases periodically (emergency medicine, travel medicine, infectious disease), create an internal protocol:

• Maintain a list of local pharmacies known to stock Coartem
• Include alternative antimalarial regimens in your malaria treatment protocol
• Train staff to check Medfinder for Providers as part of the prescribing workflow
• Keep the Novartis PAP phone number and website readily accessible

Alternative Antimalarial Options

When Coartem is unavailable or impractical, these CDC-recommended alternatives are appropriate for uncomplicated P. falciparum malaria:

MedicationGeneric AvailableTypical CostKey ConsiderationsAtovaquone/Proguanil (Malarone)Yes$30–$80Widely stocked; well-tolerated; no QT riskQuinine + DoxycyclineYes$20–$60Complex regimen; QT risk with QuinineMefloquineYes$15–$50Neuropsychiatric side effects; boxed warningChloroquineYesUnder $20Only for chloroquine-sensitive regions

Workflow Tips

To minimize prescribing friction for antimalarials in your practice:

• Build a pharmacy list: Identify 2-3 pharmacies near your practice that reliably stock Coartem. Update this list annually.
• Use Medfinder proactively: Make Medfinder for Providers a standard check before prescribing any antimalarial.
• Pre-authorize when possible: If the patient has insurance, consider initiating prior authorization at the time of prescribing rather than waiting for the pharmacy to trigger it.
• Set patient expectations: Tell patients upfront that Coartem may not be at their usual pharmacy and give them specific direction on where to go.
• Follow up quickly: For malaria patients, schedule a same-day or next-day follow-up call to confirm they obtained the medication and started treatment.

Final Thoughts

Coartem access is a solvable problem — it just requires proactive prescribing practices. By checking stock before prescribing, directing patients to the right pharmacies, preparing alternative prescriptions, and using tools like Medfinder for Providers, you can ensure your malaria patients start treatment without unnecessary delays.

For the full clinical briefing on Coartem availability, see our companion post: Coartem shortage — what providers and prescribers need to know in 2026.